XML 129 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Unaudited Condensed Consolidated Statements of Cash Flows    
Net loss $ (4,493) $ (11,392)
Adjustment to reconcile net loss to net cash used in operating activities:    
Stock based compensation - services 752 420
Stock based compensation - prepaid 0 300
Stock issued from equity incentive plan (19) 0
Gain from settlement of accounts payable 0 (26)
Gain from extinguishment of debt (734) 0
Change in fair value of contingent share consideration (1,555) 5,658
Change in fair value of convertible promissory notes (340) 0
Depreciation and amortization 1,578 164
Amortization of right of use asset 48 6
Bad debt expenses 41 14
Recovery of bad debt expense (221) 0
Loss on disposal of property, plant and equipment 41 0
Inventory reserve for obsolescence (109) (2)
Change of fair value in derivative liabilities 0 (75)
Fair value of vested stock options and restricted stock 1,839 1,069
Change in operating assets and liabilities:    
Accounts receivable (59) 85
Inventory (273) (52)
Prepaid expenses and other assets 957 (36)
Other assets (25) 0
Accounts payable (95) 139
Accrued expenses 2,538 113
Finance lease payable (6) (6)
Operating lease payable (44) 0
Contract liabilities (397) (152)
License fees (80) (5)
Cash used in operating activities (656) (3,778)
Cash flows from investing activities    
Investment in company 0 250
Purchase of intangible assets 67 8
Acquisition of property and equipment, net (32) (586)
Purchase of note receivable (200) 0
Collection of note receivable 200 0
Cash provided by (used in) investing activities (99) (844)
Cash flows from financing activities    
Proceeds from exercise of warrants 0 1,417
Proceeds from notes payable 750 649
Proceeds from related party payable 200 0
Repayment of loans payable (219) (111)
Cash provided by financing activities 731 1,955
Net increase (decrease) in cash and cash equivalents (24) (2,667)
Cash and cash equivalents, beginning of year 1,725 4,096
Cash and cash equivalents, end of year 1,701 1,429
Supplemental cash flow information    
Interest 68 3
Income taxes 0 0
Non-cash investing and financing activities:    
Common stock issued for conversion of promissory notes and accrued interest 1,834 0
Common stock issued for settlement of earnout liabilities from the acquisition of Chemistry Holdings, Inc $ 0 $ 21,701